Julie Hambleton
Director/Board Member presso IGM BIOSCIENCES, INC.
Patrimonio netto: 260 435 $ in data 31/03/2024
Provenienza dei contatti di primo grado di Julie Hambleton
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.
176
| Subsidiary | Biotechnology | 176 |
The University of California, San Francisco
51
| College/University | Other Consumer Services | 51 |
Public Company | Pharmaceuticals: Major | 34 | |
Public Company | Pharmaceuticals: Major | 26 | |
Public Company | Biotechnology | 22 | |
22
| Public Company | Pharmaceuticals: Major | 22 |
Subsidiary | Biotechnology | 11 | |
Public Company | Pharmaceuticals: Major | 8 | |
Onc.ai, Inc.
Onc.ai, Inc. Packaged SoftwareTechnology Services Onc.ai, Inc. is a digital health company that is privately held and is developing a precision oncology care management platform. The company is based in San Carlos, CA. The company aims to transform clinical decision making and is backed by premier investment firms such as the Blue Venture Fund, MassMutual Alternative Investments, and Accomplice, among others. The company is building a pipeline of physician-centered products to fulfill the potential of precision oncology. The company was founded by Akshay Nanduri, who has been the CEO since incorporation.
7
| Holding Company | Packaged Software | 7 |
Gennao Bio, Inc.
Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Gennao Bio, Inc. is a privately-held genetic medicines company that is developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing its proprietary gene monoclonal antibody (gmab) platform technology. The company is based in Pennington, NJ. The company's gmab technology uses a novel, cell-penetrating antibody to non-covalently bind to, and deliver therapeutic levels of a wide variety of nucleic acid payloads, to select cells. Gennao Bio is initially focusing on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases. The company's non-viral delivery platform offers significant advantages over traditional gene delivery systems as it can deliver multiple types of nucleic acids, allows for repeat dosing and dose optimization, and can be easily and affordably manufactured. The company was founded in 2020 by Bruce Turner, Elias Quijano, Peter M. Glazer, Stephen P. Squinto. Christopher M. Duke has been the CEO of the company since 2021.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Private Company | Pharmaceuticals: Major | 4 | |
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA.
2
| Holding Company | Miscellaneous Commercial Services | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Julie Hambleton tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
REGENERON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder Corporate Officer/Principal | |
ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Corporate Officer/Principal | |
Ignyta Operating, Inc.
Ignyta Operating, Inc. Pharmaceuticals: MajorHealth Technology Ignyta Operating, Inc. develops molecular diagnostics for cancer and immunology. It is a biotechnology company developing personalized medicines for high unmet need cancer indications, based on cancer genome mining and sequencing. The firm's products include TrailblazeDx for RA, TrailblazeTx for RA, TrailblazeDx for SLE, TrailblazePx for SLE and TrailblazeTx for SLE. The company was founded in August 2011 by Jonathan E. Lim and Gary S. Firestein and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
MYOKARDIA, INC. | Pharmaceuticals: Major | Director/Board Member Human Resources Officer | |
GUARDANT HEALTH, INC. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Undergraduate Degree Corporate Officer/Principal | |
Stanford University | College/University | Doctorate Degree Graduate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree Doctorate Degree President Graduate Degree Undergraduate Degree Graduate Degree Doctorate Degree Undergraduate Degree | |
University of Oxford | College/University | Undergraduate Degree Graduate Degree | |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
McGill University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
MIRATI THERAPEUTICS | Biotechnology | Director/Board Member Director/Board Member | |
Massachusetts Institute of Technology | College/University | Graduate Degree Graduate Degree Doctorate Degree Masters Business Admin Undergraduate Degree | |
The University of Edinburgh | College/University | Doctorate Degree Undergraduate Degree | |
Yale University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Director/Board Member Undergraduate Degree Doctorate Degree | |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | College/University | Director/Board Member Doctorate Degree | |
University of Arizona | College/University | Undergraduate Degree Undergraduate Degree | |
University of Michigan | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
University of New Hampshire | College/University | Doctorate Degree Doctorate Degree | |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Hospital/Nursing Management | Director/Board Member Director/Board Member Corporate Officer/Principal | |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal President | |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Director/Board Member Director/Board Member | |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
IGNYTA INC | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Chairman Chief Executive Officer | |
Harvard Medical School | College/University | Director/Board Member Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree | |
Stanford University School of Medicine | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
AUDENTES THERAPEUTICS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal Director/Board Member | |
GLOBAL BLOOD THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
Action Potential Venture Capital
Action Potential Venture Capital Investment ManagersFinance Action Potential Venture Capital (Action Potential Venture) is a venture capital subsidiary of GlaxoSmithKline Plc founded in 2013. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Analyst | |
DECIPHERA PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
OLEMA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Deciphera Pharmaceuticals LLC
Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Biotechnology | Chairman Chief Executive Officer | |
International Society for Biological Therapy of Cancer
International Society for Biological Therapy of Cancer Miscellaneous Commercial ServicesCommercial Services The International Society for Biological Therapy of Cancer operates as a professional society of influential scientists, academicians, researchers, clinicians, and government representatives. The non-profit company is based in Milwaukee, WI. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
DENALI THERAPEUTICS INC. | Biotechnology | Founder Founder | |
TARSUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 48 |
Regno Unito | 3 |
Canada | 2 |
Settori
Health Technology | 26 |
Consumer Services | 17 |
Commercial Services | 5 |
Health Services | 4 |
Finance | 3 |
Posizioni
Director/Board Member | 549 |
Corporate Officer/Principal | 276 |
Independent Dir/Board Member | 191 |
Chairman | 100 |
Undergraduate Degree | 88 |
Contatti più connessi
Insiders | |
---|---|
Myrtle Potter | 41 |
Stephen P. Squinto | 40 |
Kapil Dhingra | 39 |
Jonathan Fleming | 36 |
Ian Clark | 35 |
Daniel Lynch | 32 |
Louis Lavigne | 32 |
Bihua Chen | 32 |
William Ringo | 32 |
Julie Cherrington | 32 |
Laurie Glimcher | 30 |
Freda Lewis-Hall | 29 |
Felix Baker | 28 |
Marc Tessier-Lavigne | 24 |
Thomas Hawes | 23 |
- Borsa valori
- Insiders
- Julie Hambleton
- Connessioni Società